Insider Transactions and Holdings
-
Entity Type
-
Individual
-
Role
-
Svp And Cfo
-
Stock Symbol
-
CLDX on Nasdaq
Samuel Bates Martin - trading volume in the past year for Celldex Therapeutics, Inc.
| Class |
Num Shares |
Value |
Price $ |
Transaction Date |
Ownership |
Underlying Class |
Underlying Amount |
| Common Stock |
28.1K |
$996K |
$35.42 |
Jun 14, 2024 |
Direct |
|
|
| Incentive Stock Option (Right to Buy) |
63.6K |
|
|
Jun 14, 2024 |
Direct |
Common Stock |
|
| Sym |
Class |
Transaction |
% |
Value $ |
* Price $ |
Shares |
Shares After |
Date |
Ownership |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.